These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23639230)

  • 1. Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.
    Kamran MZ; Gude RP
    Biomed Pharmacother; 2013 Jun; 67(5):399-405. PubMed ID: 23639230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line.
    Kamran MZ; Gude RP
    Biomed Pharmacother; 2012 Dec; 66(8):617-26. PubMed ID: 23089470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.
    Dong Y; Lu B; Zhang X; Zhang J; Lai L; Li D; Wu Y; Song Y; Luo J; Pang X; Yi Z; Liu M
    Carcinogenesis; 2010 Dec; 31(12):2097-104. PubMed ID: 20732905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline triggers autophagy via ER stress response that interferes with Pentoxifylline induced apoptosis in human melanoma cells.
    Sharma K; Ishaq M; Sharma G; Khan MA; Dutta RK; Majumdar S
    Biochem Pharmacol; 2016 Mar; 103():17-28. PubMed ID: 26793997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.
    Liu L; Nam S; Tian Y; Yang F; Wu J; Wang Y; Scuto A; Polychronopoulos P; Magiatis P; Skaltsounis L; Jove R
    Cancer Res; 2011 Jun; 71(11):3972-9. PubMed ID: 21610112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curbing the focal adhesion kinase and its associated signaling events by pentoxifylline in MDA-MB-231 human breast cancer cells.
    Goel PN; Gude RP
    Eur J Pharmacol; 2013 Aug; 714(1-3):432-41. PubMed ID: 23872375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma.
    Dua P; Ingle A; Gude RP
    Int J Cancer; 2007 Oct; 121(7):1600-8. PubMed ID: 17582610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell.
    Zhang X; Song Y; Wu Y; Dong Y; Lai L; Zhang J; Lu B; Dai F; He L; Liu M; Yi Z
    Int J Cancer; 2011 Nov; 129(10):2502-11. PubMed ID: 21207415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
    Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
    Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
    Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
    Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling.
    Cao HH; Tse AK; Kwan HY; Yu H; Cheng CY; Su T; Fong WF; Yu ZL
    Biochem Pharmacol; 2014 Feb; 87(3):424-34. PubMed ID: 24275163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocarpusflavone A inhibits cell growth of skin cutaneous melanoma by suppressing STAT3 signaling.
    Meng H; Pang Y; Liu G; Luo Z; Tan H; Liu X
    J Dermatol Sci; 2020 Dec; 100(3):201-208. PubMed ID: 33127205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking of Akt/NF-kappaB signaling by pentoxifylline inhibits platelet-derived growth factor-stimulated proliferation in Brown Norway rat airway smooth muscle cells.
    Chiou YL; Shieh JJ; Lin CY
    Pediatr Res; 2006 Dec; 60(6):657-62. PubMed ID: 17065572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12.
    Bid HK; Oswald D; Li C; London CA; Lin J; Houghton PJ
    PLoS One; 2012; 7(4):e35513. PubMed ID: 22530037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.